Inhibition of osteogenesis in vitro by a cigarette smoke-associated hydrocarbon combined with Porphyromonas gingivalis lipopolysaccharide: Reversal by resveratrol

Journal of Periodontology

Volumn 75, Issue 7, 2004, Pages 939-948

  Andreou, V ^a   D'Addario, M ^a   Zohar, R ^a   Sukhu, B ^a   Casper, R F ^a   Ellen, Richard P ^a   Tenenbaum, H C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alveolar bone loss etiology; Animal studies; Aryl hydrocarbons adverse effects; Bone barrow; Lipopolysaccharides; Osteogenesis; Porphyromonas gingivalis; Receptors, aryl hydrocarbons antagonists and inhibitors; Resveratrol; Smoking adverse effects

Indexed keywords

ALKALINE PHOSPHATASE; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; CELL PROTEIN; CIGARETTE SMOKE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PHYTOALEXIN; PROSTAGLANDIN DERIVATIVE; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR PARAMETERS; CIGARETTE SMOKING; CLINICAL PROTOCOL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME ACTIVITY; FRACTURE HEALING; GENETIC TRANSCRIPTION; IN VITRO STUDY; INCUBATION TIME; MALE; MEASUREMENT; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ALVEOLAR BONE LOSS; ANIMALS; BENZO(A)PYRENE; CELLS, CULTURED; DRUG SYNERGISM; LIPOPOLYSACCHARIDES; MALE; OSTEOGENESIS; PORPHYROMONAS GINGIVALIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKE; STILBENES; TOBACCO;

EID: 4444248870     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.7.939     Document Type: Article

References (51)

1. Miyata Y, Takeda H, Kitano S, et al. Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics. Infect Immun 1997;65:3513-3519.
2. Li L, Khansari A, Shapira L, et al. Contribution of interleukin-11 and prostaglandin(s) in lipopolysaccharide-induced bone resorption in vivo. Infect Immun 2002;70: 3915-3922.
3. Loomer PM, Sigusch B, Sukhu B, et al. Direct effects of metabolic products and sonicated extracts of Porphyromonas gingivalis 2561 on osteogenesis in vitro. Infect Immun 1994;62:1289-1297.
4. Loomer PM, Ellen RP, Tenenbaum HC. Osteogenic and osteoclastic cell interaction: Development of a co-culture system. Cell Tissue Res 1998;294:99-108.
5. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002;29:177-206.
6. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med 2000;11:356-365.
7. Genco R, Kinane D. Smoking and periodontitis. J Int Acad Periodontol 1999;1:21-33.
8. Bergström J, Eliasson S. Noxious effect of cigarette smoking on periodontal health. J Periodontal Res 1987;22: 513-517.
9. Haber J, Wattles J, Crowley M, et al. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64:16-23.
10. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-270.
11. Chang YC, Huang FM, Tai KW, et al. Mechanisms of cytotoxicity of nicotine in human periodontal ligament fibroblast cultures in vitro. J Periodontal Res 2002;37: 279-285.
12. Bock KW. Aryl hydrocarbon or dioxin receptor: Biologic and toxic responses. Rev Physiol Biochem Pharmacol 1994;125:1-42.
13. Chun YJ, Kim MY, Guengerich FP. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999;262:20-24.
14. Casper RF, Quesne M, Rogers IM, et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol Pharmacol 1999;56:784-790.
15. Ciolino HP, Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999; 56:760-767.
16. Singh SU, Casper RF, Fritz PC, et al. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 2000;167:183-195.
17. Fremont L. Biological effects of resveratrol. Life Sci 2000;66:663-673.
18. Gehm BD, McAndrews JM, Chien PY, et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci (USA) 1997;94:14138-14143.
19. Ellen RP, Schwarz-Faulkner S, Grove DA. Coaggregation among periodontal pathogens, emphasizing Bacteroides gingivalis - Actinomyces viscosus cohesion on a saliva-coated mineral surface. Can J Microbiol 1988;34: 299-306.
20. Goulbourne PA, Ellen RP. Evidence that Porphyromonas (Bacteroides) gingivalis fimbriae function in adhesion to Actinomyces viscosus. J Bacteriol 1991;173:5266-5274.
21. Shapira L, Champagne C, Van Dyke TE, et al. Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis. Infect Immun 1998;66:2736-2742.
22. Westphal O, Jann K. Methods in Carbohydrate Chemistry, 5th ed. New York: Academic Press; 1965:83-91.
23. Kadono H, Kido J, Kataoka M, et al. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999;67: 2841-2846.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
25. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330.
26. McCulloch CA, Tenenbaum HC. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec 1986;215:397-402.
27. 2 and IL-1beta production in gingival fibroblast cells from old rats. Exp Gerontol 1999;34:379-392.
28. D'Addario M, Ahmad A, Xu JW, et al. Epstein-Barr virus envelope glycoprotein gp350 induces NF-kappaB activation and IL-1beta synthesis in human monocytes-macrophages involving PKC and PI3-K. FASEB J 1999; 13:2203-2213.
29. Champagne CM, Holt SC, Van Dyke TE, et al. Lipopolysaccharide isolated from Porphyromonas gingivalis grown in hemin-limited chemostat conditions has a reduced capacity for human neutrophil priming. Oral Microbiol Immunol 1996;11:319-325.
30. Nair BC, Mayberry WR, Dziak R, et al. Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res 1983;18:40-49.
31. Iino Y, Hopps RM. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths. Arch Oral Biol 1984;29:59-63.
32. Stashenko P, Jandinski JJ, Fujiyoshi P, et al. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991;62:504-509.
33. Lamont RJ, Jenkinson HF. Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998;62:1244-1263.
34. 2 stimulates preosteoblast replication: An autoradiographic study in cultured fetal rat calvariae. Exp Cell Res 1994; 212:314-320.
35. 2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-I. Endocrinology 1993; 133:1504-1510.
36. Raisz LG, Pilbeam CC, Fall PM. Prostaglandins: Mechanisms of action and regulation of production in bone. Osteoporos Int 1993;3(Suppl. 1): 136-140.
37. Raisz LG. Prostaglandins and bone: Physiology and pathophysiology. Osteoarthritis Cartilage 1999;7:419-421.
38. Woodiel FN, Fall PM, Raisz LG. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res 1996;11:1249-1255.
39. Jee WS, Ma YF. The in vivo anabolic actions of prostaglandins in bone. Bone 1997;21:297-304.
40. Raisz LG. Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med 2001;110(Suppl. 3A):43S-45S.
41. Kjaersgaard-Andersen P, Nafei A, Teichert G, et al. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993;64:639-642.
42. 1-induced hyperostosis: Clinicopathologic correlations and possible pathogenetic mechanisms. Pediatr Pathol Lab Med 1996;16:489-507.
43. Bergström J, Eliasson S, Dock J. A 10-year prospective study of tobacco smoking and periodontal health. J Periodontol 2000;71:1338-1347.
44. Grossi SG, Zambon J, Machtei EE, et al. Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997;128:599-607.
45. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28:377-388.
46. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
47. Subbaramaiah K, Michaluart P, Chung WJ, et al. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann N Y Acad Sci 1999;889: 214-223.
48. Subbaramaiah K, Chung WJ, Michaluart P, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875-21882.
49. Moreno JJ. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 2000;294:333-338.
50. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000;59: 865-870.
51. Mizutani K, Ikeda K, Kawai Y, et al. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 1998;253: 859-863.